Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Market Cap : 29.94B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 25.24B |
| September 03, 2026 | 24.87B |
| September 02, 2026 | 24.70B |
| September 01, 2026 | 24.95B |
| August 31, 2026 | 25.03B |
| August 28, 2026 | 25.08B |
| August 27, 2026 | 27.16B |
| August 26, 2026 | 26.56B |
| August 25, 2026 | 26.36B |
| August 24, 2026 | 26.28B |
| August 21, 2026 | 26.23B |
| August 20, 2026 | 26.62B |
| August 19, 2026 | 27.03B |
| August 18, 2026 | 27.01B |
| August 17, 2026 | 26.19B |
| August 14, 2026 | 26.16B |
| August 13, 2026 | 26.22B |
| August 12, 2026 | 26.13B |
| August 11, 2026 | 25.47B |
| August 10, 2026 | 25.86B |
| August 07, 2026 | 26.26B |
| August 06, 2026 | 25.38B |
| August 05, 2026 | 25.00B |
| August 04, 2026 | 25.00B |
| August 03, 2026 | 24.00B |
| Date | Value |
|---|---|
| July 31, 2026 | 24.43B |
| July 30, 2026 | 24.87B |
| July 29, 2026 | 23.68B |
| July 28, 2026 | 24.38B |
| July 27, 2026 | 25.01B |
| July 24, 2026 | 25.22B |
| July 23, 2026 | 25.28B |
| July 22, 2026 | 25.15B |
| July 21, 2026 | 25.18B |
| July 20, 2026 | 24.53B |
| July 17, 2026 | 24.86B |
| July 16, 2026 | 24.44B |
| July 15, 2026 | 25.13B |
| July 14, 2026 | 25.15B |
| July 13, 2026 | 24.86B |
| July 10, 2026 | 25.91B |
| July 09, 2026 | 26.52B |
| July 08, 2026 | 26.00B |
| July 07, 2026 | 26.16B |
| July 06, 2026 | 25.49B |
| July 02, 2026 | 25.31B |
| July 01, 2026 | 25.23B |
| June 30, 2026 | 25.49B |
| June 29, 2026 | 25.02B |
| June 26, 2026 | 24.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oxford Biomedica Plc | 863.16M |
| Bicycle Therapeutics Plc | 210.32M |
| Arbutus Biopharma Corp. | 1.023B |
| Moderna, Inc. | 55.96B |
| Adaptimmune Therapeutics Plc | 7.103M |
Market Cap Related Metrics
| PS Ratio | 4002.83 |
| Price to Book Value | 7.076 |
| Price | 41.43 |
| Earnings Yield | -1.06% |